aibioAnnexon holders approve raising authorized common shares to 500,000,000
Tickers ANNX
Annexon's stockholders approved raising authorized common stock from 300,000,000 to 500,000,000 shares on June 11, 2026, with 8,795,454 abstentions and no reason given for the increase.
Key facts
- Company
- Annexon, Inc. (NASDAQ: ANNX)
- News type
- Listings
- Primary source
- Annexon, Inc. 8-K (2026-06-12)
Annexon, Inc. (Nasdaq: ANNX) reported the results of its 2026 Annual Meeting of Stockholders in a Form 8-K dated June 11, 2026 and filed June 12, 2026. The filing is made under Item 5.07, which covers the results of votes submitted to security holders. Stockholders voted on four matters: the election of two directors, the ratification of the auditor, an advisory vote on executive pay and the share increase. The main item was an amendment to the company's amended and restated certificate of incorporation that raises the number of authorized shares of common stock from 300,000,000 to 500,000,000. Authorized shares are the ceiling on how many shares a company can issue. Raising the ceiling does not issue any stock by itself, but it gives the company room to do so, and the 8-K does not say what that room is for.
The vote on the share increase
The amendment received 129,051,256 votes for, 4,374,799 against and 8,795,454 abstentions. The filing reports no broker non-votes on this item. Abstentions are not votes against, but 8,795,454 shares abstained, and the 8-K gives no breakdown of who abstained or why.
Director elections
Bettina M. Cockroft, M.D. and Douglas Love, Esq. were elected as Class III directors for three-year terms expiring at the 2029 annual meeting. Cockroft received 101,594,745 votes for and 22,807,949 withheld, the larger withheld total of the two nominees. Love received 107,491,451 votes for and 16,911,243 withheld. Each election recorded 17,818,815 broker non-votes. The withheld totals are the record of holders who declined to back each nominee.
Auditor and pay vote
Stockholders ratified the Audit Committee's selection of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 142,016,122 votes for, 185,546 against and 19,841 abstentions. The advisory vote on the pay of the named executive officers drew 122,347,513 votes for and 1,986,387 against, with 68,794 abstentions and 17,818,815 broker non-votes. The pay vote is advisory, so its result does not bind the board, and the 8-K reports no change to the pay program itself. The auditor ratification had no broker non-votes.
Losses behind the request
The company's annual report for 2025, filed March 30, 2026, shows a net loss of $206.7 million, up from $138.2 million in 2024. Research and development expense rose to $184.7 million from $119.4 million. Cash used in operations was $186.4 million in 2025, compared with $118.0 million the year before. At December 31, 2024 the company held cash and cash equivalents of $49.5 million and short-term investments of $262.5 million. The 8-K gives no cash balance for any date and contains no financial statements, so it cannot show how much cash the company holds against that spending.
The company and the signatory
Annexon is incorporated in Delaware, its commission file number is 001-39402, and its principal executive offices are at 1400 Sierra Point Parkway in Brisbane, California. Its common stock, par value $0.001 per share, trades on the Nasdaq Stock Market under the symbol ANNX. Jennifer Lew, executive vice president and chief financial officer, signed the 8-K.
What comes next
The filing sets no date for any stock sale and names no planned issuance. A larger ceiling gives the company room to issue more stock, which would dilute existing holders if used, and the 8-K gives no reason the increase was sought. Any sale of the new shares would appear in a later filing.